ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.430
+0.650 (17.20%)
At close: Mar 6, 2026
-18.42% (1Y)
| Market Cap | 1.91B -15.0% |
| Revenue (ttm) | 134.60M +1,584.9% |
| Net Income | -331.67M |
| EPS | -0.84 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,337,800 |
| Average Volume | 1,446,400 |
| Open | 3.960 |
| Previous Close | 3.780 |
| Day's Range | 3.960 - 4.700 |
| 52-Week Range | 3.430 - 16.800 |
| Beta | 0.97 |
| RSI | 49.14 |
| Earnings Date | Mar 25, 2026 |